Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis

被引:9
|
作者
Talbot, Jacob [1 ]
Chow, Helene Hojsgaard [1 ]
Mahler, Mie [1 ]
Buhelt, Sophie [1 ]
Hansen, Rikke Holm [1 ]
Lundell, Henrik [2 ]
Vinther-Jensen, Tua [3 ]
Hellem, Marie N. N. [3 ]
Nielsen, Jorgen E. [3 ]
Siebner, Hartwig Roman [2 ,4 ,5 ]
Essen, Marina R. von [1 ]
Sellebjerg, Finn [1 ]
机构
[1] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Rigshospitalet, Valdemar Hansens Vej 17, 7, 5, DK-2600 Glostrup, Denmark
[2] Copenhagen Univ Hosp Amager & Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Danish Dementia Res Ctr, Neurogenet Clin, Rigshospitalet, Copenhagen, Denmark
[4] Copenhagen Univ Hosp Bispebjerg & Frederiksberg, Dept Neurol, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
基金
欧洲研究理事会;
关键词
ABSTRACT; MECHANISMS; DIAGNOSIS; PLACEBO;
D O I
10.1016/j.msard.2022.104209
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Objectives: It is unclear to what extent intrathecal inflammation contributes to the pathogenesis in primary progressive multiple sclerosis (PPMS). We conducted an exploratory study to investigate the degree of intrathecal inflammation and its association with biomarkers of disease activity and severity in patients with PPMS.Methods: We included patients with PPMS who participated in a randomized controlled trial conducted at the Danish Multiple Sclerosis Center, patients with relapsing-remitting multiple sclerosis (RRMS) and healthy controls. We analyzed concentrations of a panel of cytokines in CSF using electrochemiluminescence assays. We then explored the relationship between cytokines found in increased CSF concentrations in patients with PPMS (compared with healthy controls) with CSF concentrations of neurofilament light chain (NFL) and myelin basic protein (MBP), IgG-index, and magnetic resonance imaging (MRI) metrics (volume, magneti-zation transfer ratio and diffusion tensor imaging) from lesions, normal-appearing white matter, and cortical grey matter.Results: We included 59 patients with PPMS, 40 patients with RRMS, and 21 healthy controls. In patients with PPMS, CSF concentrations of CC chemokine ligand 3 (CCL-3), CXC chemokine ligand 8 (CXCL-8), CXCL-10, interleukin (IL)-10, IL-15, and vascular endothelial growth factor (VEGF)-A were increased compared with healthy controls and comparable with CSF concentrations in patients with RRMS. In addition, patients with PPMS had increased CSF concentrations of IL-12p40, IL -17A, tumor necrosis factor (TNF)-alpha, and lymphotoxin (LT)-alpha compared with healthy controls, but concentrations of these cytokines were even higher in patients with RRMS. For the remaining seven cytokines (CCL22, interferon-gamma, IL-5, IL-7, IL-16, IL-22, IL-27), we found no difference between patients with PPMS and healthy controls. CSF concentrations of NFL and MBP correlated weakly with concentrations of IL-15, while the remaining proinflammatory cytokines were not associated with CSF concentrations of NFL or MBP. The IgG-index correlated with four cytokines (IL-10, IL-12p40, TNF-alpha, and LT-alpha). We did not observe any significant as-sociations between MRI metrics and CSF biomarkers of inflammation.Discussion: In this exploratory study, we found few and weak associations between intrathecal inflammation and the extent of neuroaxonal damage and demye-lination, and no associations between intrathecal inflammation and MRI metrics, in patients with PPMS. Our findings suggest that, for patients with PPMS, these measures of intrathecal inflammation are not associated with the extent of neuroaxonal injury, demyelination, and disease severity, and these processes may therefore have less relevance in PPMS than in relapsing forms of MS.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Cerebrospinal fluid and urinary biomarkers in multiple sclerosis
    Dobson, R.
    Topping, J.
    Davis, A.
    Thompson, E.
    Giovannoni, G.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (05): : 321 - 327
  • [22] Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis
    Shedko E.D.
    Tyumentseva M.A.
    Neuroscience and Behavioral Physiology, 2020, 50 (5) : 527 - 533
  • [23] Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis
    Petrou, Panayiota
    Kassis, Ibrahim
    Ginzberg, Ariel
    Hallimi, Michelle
    Karussis, Dimitrios
    STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (01) : 55 - 58
  • [24] Cerebrospinal Fluid Biomarkers Associated with Intrathecal Cell Therapy in Patients with Progressive Multiple Sclerosis
    Kizilbash, Cara
    Carlson, Alyssa
    Harris, Violaine
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [25] Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis
    Stoop, Marcel P.
    Singh, Vaibhav
    Dekker, Lennard J.
    Titulaer, Mark K.
    Stingl, Christoph
    Burgers, Peter C.
    Smitt, Peter A. E. Sillevis
    Hintzen, Rogier Q.
    Luider, Theo M.
    PLOS ONE, 2010, 5 (08):
  • [26] Primary progressive multiple sclerosis: cerebrospinal fluid considerations - Question and answer session
    Oger, J
    Freedman, M
    Miller, D
    Weinshenker, BG
    Carter, J
    Vollmer, T
    Kaufman, M
    MULTIPLE SCLEROSIS, 2004, 10 : S34 - S35
  • [27] Cerebrospinal Fluid Determinants of Outcome in Progressive Multiple Sclerosis
    Tang, Junger
    Crusan, Daniel
    Tutuncu, Melih
    Abou Zeid, Nuhad
    Kale, Nilufer
    Atkinson, Elizabeth
    Kantarci, Orhun
    NEUROLOGY, 2011, 76 (09) : A65 - A66
  • [28] Chitotriosidase concentrations are increased in cerebrospinal fluid and scale with diffuse cerebral white matter damage in primary progressive multiple sclerosis
    Talbot, Jacob
    Chow, Helene Hoejsgaard
    Ratzer, Rikke
    Hansen, Rikke Holm
    Buhelt, Sophie
    Mahler, Mie Reith
    Lundell, Henrik
    von Essen, Marina Rode
    Siebner, Hartwig
    Kosa, Peter
    Bielekova, Bibiana
    Sellebjerg, Finn
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 887 - 888
  • [29] Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis
    Augutis, Kristin
    Axelsson, Markus
    Portelius, Erik
    Brinkmalm, Gunnar
    Andreasson, Ulf
    Gustavsson, Mikael K.
    Malmestrom, Clas
    Lycke, Jan
    Blennow, Kaj
    Zetterberg, Henrik
    Mattsson, Niklas
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 543 - 552
  • [30] Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients
    Fitzner, Brit
    Hecker, Michael
    Zettl, Uwe Klaus
    AUTOIMMUNITY REVIEWS, 2015, 14 (10) : 903 - 913